+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group



Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group



Cardiology 85(3-4): 244-254



Simvastatin and pravastatin, two 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, were compared in a multinational, randomized, double-blind trial. Patients demonstrating moderate hypercholesterolemia after 10 weeks on a lipid-lowering diet received 6 weeks of treatment with 5 mg/day simvastatin (n = 143) or 10 mg/day pravastatin (n = 138); the simvastatin dose was increased to 10 mg for an additional 6 weeks while the pravastatin dose remained at 10 mg. When administered at lower or equivalent daily doses, simvastatin was significantly more effective than pravastatin in reducing total and low-density lipoprotein (LDL) cholesterol. Reductions in plasma total and LDL cholesterol were significantly greater with 5 mg simvastatin (16 and 23%) compared to 10 mg pravastatin (12 and 18%; p < or = 0.01). The efficacy of 10 mg simvastatin in lowering these lipid parameters was also superior (19 vs. 11% and 27 vs. 17%, respectively; p < or = 0.01). At 6 and 12 weeks, a significantly higher percentage of simvastatin patients (45 and 59%, respectively) achieved a desirable LDL cholesterol level of < 130 mg/dl (< 3.4 mmol/l) compared to pravastatin patients (32-33%; p < or = 0.05). Both drugs were well tolerated and had comparable safety profiles.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008349517

Download citation: RISBibTeXText

PMID: 7987882


Related references

Comparative Efficacy and Tolerability of 5 and 10 mg Simvastatin and 10 mg Pravastatin in Moderate Primary Hypercholesterolemia. Cardiology 85(3-4): 244-254, 1994

Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia (multicountry comparative study). American Journal of Cardiology 70(15): 1281-1286, 1992

Efficacy and tolerability of simvastatin 20 mg vs pravastatin 20 mg in patients with primary hypercholesterolemia. Acta Cardiologica 48(6): 541-554, 1993

Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia. Clinical Therapeutics 13(4): 500-510, 1991

Comparative study of the efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolaemia. Drug Investigation. 6(6): 353-361, 1993

Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. American Journal Of Cardiology. 71(16): 1408-1414, 1993

The efficacy and safety of pravastatin and simvastatin in patients with primary hypercholesterolemia. Current Therapeutic Research 51(3): 422-430, 1992

Comparative effects of simvastatin and pravastatin on cholesterol synthesis in patients with primary hypercholesterolemia. Atherosclerosis 118(2): 251-258, 1995

Efficacy and safety of pravastatin and simvastatin in patients with primary hypercholesterolemia compared in a cross-over study. (see Book Title) [Author] Gotto, A M Jr , et al (Ed ) Treatment of severe dyslipoproteinemia in the prevention of coronary heart disease; 3rd International Symposium, Munich, Germany, October 17-18, 1990 ix+366p S Karger AG: Basel, Switzerland; New York, New York, USA Illus ISBN 3-8055-5539-3: 271-279, 1992

Long-term efficacy and tolerability of pravastatin in hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus. Hyogo Pravastatin Study Group. Diabetes Research and Clinical Practice 27(1): 61-68, 1995

Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin. American Journal of Cardiology 73(9): 723-724, 1994

Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II. Archives of Internal Medicine 153(11): 1321-1329, 1993

Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin. Recenti Progressi in Medicina 87(11): 538-542, 1996

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and Fluvastatin in patients with hypercholesterolemia (The CURVES Study). American Journal of Cardiology 81(5): 582-587, 1998

Crossover trial of simvastatin versus pravastatin in patients with primary hypercholesterolemia. Journal of Cardiovascular Pharmacology 30(1): 142-147, 1997